Gilead (NASDAQ: GILD) officer sells 3,000 shares under 10b5-1 plan

Q: How many Gilead (GILD) shares did Johanna Mercier sell in this Form 4?

Johanna Mercier sold a total of 3,000 shares of Gilead common stock. The Form 4 shows three open-market sale transactions on June 15, 2026, with share amounts of 450, 1,070, and 1,480, which together sum to 3,000 shares.

Q: At what prices were Johanna Mercier’s Gilead (GILD) shares sold?

The reported sales occurred at prices up to $125.40 per share . Footnotes state that sale prices ranged from $122.79 to $123.785 and from $123.81 to $124.23 , while the individual line items include prices such as $125.40 and $123.9958.

Q: Does this Gilead (GILD) Form 4 show a pre-planned Rule 10b5-1 sale?

Yes. A footnote states the transactions were made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025. Such plans pre-schedule trades, indicating these sales were arranged in advance rather than timed in response to short-term market events.

Q: What role does Johanna Mercier have at Gilead (GILD) in this Form 4?

Johanna Mercier is listed as an officer of Gilead Sciences , serving as Chief Commercial & Corporate Affairs Officer. The Form 4 identifies her insider status, which requires reporting transactions like these sales of Gilead common stock to the SEC.

Q: What type of transaction is reported for Gilead (GILD) in this Form 4?

The filing reports open-market sales of common stock , coded as “S” transactions. Each entry is classified as a non-derivative sale, with the transaction description indicating sales in the open market or private transactions and no derivative exercises reported.

Filing Impact

(Moderate)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Gilead Sciences executive Johanna Mercier reported open-market sales of 3,000 shares of Gilead common stock. The transactions occurred on June 15, 2026 at prices ranging from $122.79 to $125.40 per share, as described in the footnotes.

The filing states that these sales were made under a pre-arranged Rule 10b5-1 trading plan adopted on February 20, 2025. After the transactions, Mercier directly holds 124,234 shares of Gilead common stock, according to the reported post-transaction balance.

Insider Trade Summary 10b5-1

Net Seller: 3,000 shares ($371,762)

Net Sell 3 txns

Insider Mercier Johanna

Role Chief Comm & Corp Aff Officer

Sold 3,000 shs ($372K)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,480	$123.4166	$183K
Sale	Common Stock	1,070	$123.9958	$133K
Sale	Common Stock	450	$125.40	$56K

Holdings After Transaction: Common Stock — 125,754 shares (Direct, null)

Footnotes (1)

The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025. Sale prices for the transactions reported range from $122.79 to $123.785. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. Sale prices for the transactions reported range from $123.81 to $124.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.

Key Figures

Shares sold: 3,000 shares Highest reported line-item sale price: $125.40 per share Reported sale price ranges: $122.79–$124.23 per share +2 more

5 metrics

Shares sold 3,000 shares Total common shares sold on June 15, 2026

Highest reported line-item sale price $125.40 per share One of the open-market sale transactions on June 15, 2026

Reported sale price ranges $122.79–$124.23 per share Price ranges described in footnotes F2 and F3

Shares held after transactions 124,234 shares Direct common stock ownership after June 15, 2026 sales

10b5-1 plan adoption date February 20, 2025 Date the pre-arranged trading plan was adopted

Key Terms

Rule 10b5-1 trading plan, open-market sale, Form 4, non-derivative, +1 more

5 terms

Rule 10b5-1 trading plan regulatory

"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Form 4 regulatory

"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

non-derivative financial

"transaction_type": "non-derivative""

Common Stock financial

"security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/16/2026 - 06:02 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mercier Johanna

(Last)

(First)

(Middle)

GILEAD SCIENCES, INC.

333 LAKESIDE DRIVE

(Street)

FOSTER CITY

CALIFORNIA

94404

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GILEAD SCIENCES, INC. [ GILD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Comm & Corp Aff Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/15/2026		S⁽¹⁾		1,480	D	$123.4166⁽²⁾	125,754	D
Common Stock	06/15/2026		S⁽¹⁾		1,070	D	$123.9958⁽³⁾	124,684	D
Common Stock	06/15/2026		S⁽¹⁾		450	D	$125.4	124,234	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.

2. Sale prices for the transactions reported range from $122.79 to $123.785. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.

3. Sale prices for the transactions reported range from $123.81 to $124.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.

Remarks:

	/s/ Amy Kim by Power of Attorney for Johanna Mercier	06/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

How many Gilead (GILD) shares did Johanna Mercier sell in this Form 4?

Johanna Mercier sold a total of 3,000 shares of Gilead common stock. The Form 4 shows three open-market sale transactions on June 15, 2026, with share amounts of 450, 1,070, and 1,480, which together sum to 3,000 shares.

At what prices were Johanna Mercier’s Gilead (GILD) shares sold?

The reported sales occurred at prices up to $125.40 per share. Footnotes state that sale prices ranged from $122.79 to $123.785 and from $123.81 to $124.23, while the individual line items include prices such as $125.40 and $123.9958.

Does this Gilead (GILD) Form 4 show a pre-planned Rule 10b5-1 sale?

Yes. A footnote states the transactions were made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025. Such plans pre-schedule trades, indicating these sales were arranged in advance rather than timed in response to short-term market events.

How many Gilead (GILD) shares does Johanna Mercier hold after these sales?

After the reported transactions, Johanna Mercier directly holds 124,234 shares of Gilead common stock. This post-transaction balance appears in the Form 4 table and reflects her remaining direct ownership following the June 15, 2026 open-market sales.

What role does Johanna Mercier have at Gilead (GILD) in this Form 4?

Johanna Mercier is listed as an officer of Gilead Sciences, serving as Chief Commercial & Corporate Affairs Officer. The Form 4 identifies her insider status, which requires reporting transactions like these sales of Gilead common stock to the SEC.

What type of transaction is reported for Gilead (GILD) in this Form 4?

The filing reports open-market sales of common stock, coded as “S” transactions. Each entry is classified as a non-derivative sale, with the transaction description indicating sales in the open market or private transactions and no derivative exercises reported.